IMPROVED MENINGITIS VACCINE

POST 01124E : IMPROVED MENINGITIS VACCINE Follow-up on Post 01104E 18 July 2007 _____________________________________ In Post 01104E we informed you that an "Improved Meningitis Vaccine for Africa Could Signal Eventual End to Deadly Scourge". Robert Davis and Evelyn Chege from UNICEF/ESARO have circulated since a series of background articles, all quite interesting. Thanks for having sent to us. _____________________________________ "The Meningitis Vaccine Project" by F. Mark Laforce, Kader Konde, Simonetta Viviani and Marie-Pierre Préziosi, in press in Vaccine. "The promise of conjugate vaccines for Africa" by Marie Paule Kieny and F. Mark Laforce, also in press in Vaccine. "Public-Private Partnership to Develop an Affordable Vaccine for an Emergent Threat: The Trivalent Neisseria meningitidis ACW135 Polysaccharide Vaccine" by Christopher B. Nelson, Maureen Birmingham, Alejandro Costa, Joëlle Daviaud, William Perea, Marie-Paule Kieny and Daniel Tarantola, published in a supplement to the American Journal of Public Health, Vol. 97, No. S1, 2007. The following articles are all in press, to be soon published in Vaccine. "An evaluation of the immunogenicity and safety of a new trivalent meningococcal polysaccharide vaccine" by Daniel Chandramohan, Abraham Hodgson, Paul Coleman, Rita Baiden, Kwaku Asante, Elizabeth Awine, Seth Owusu-Agyei, Dominique Boutriau, Christopher B. Nelson and Brain Greenwood. "Effectiveness of a trivalent serogroup A/C/W135 meningococcal polysaccharide vaccine in Burkina Faso, 2003" by Montse Soriano-Gabarró, Laurent Toé, Sylvestre R.M. Tiendrebeogo, Christopher B. Nelson, Moumouni Dabal, Mamoudou H. Djingarey, Brian Plikaytis and Nancy Rosenstein (WHO Trivalent Vaccine Impact Assessment Study Group) "Safety of a trivalent meningococcal ACW135 vaccine among young children in Ethiopia " by Abraham Aseffa, Ahmed Bedru , Lawrence Yamuaha, Demis Arga, Alemayehu Worku, Daniel Chandramohan, Christopher B. Nelson and Howard D. Engers. "Monitoring of adverse events during the 2003 mass vaccination campaign with a trivalent meningococcal A/C/W135 polysaccharide vaccine in Burkina Faso " by Adwoa D. Bentsi-Enchill, Issaka Zongob, Selma Khamassi, Robert Pless, Rigobert Thombianod, Sylvestre Tiéndrebéogo, Christopher B. Nelson and Philippe Duclos. ______________________________________________________________________________ All members of the TechNet21 e-Forum are invited to send comments on any posting or to use the forum to raise a new discussion or request technical information in relation to immunization services. The comments made in this forum are the sole responsibility of the writers and do not in any way mean that they are endorsed by any of the organizations and agencies to which the authors may belong. ______________________________________________________________________________ Visit the TECHNET21 Website at http://www.technet21.org You will find instructions to subscribe, a direct access to archives, links to reference documents and other features. ______________________________________________________________________________ To UNSUBSCRIBE, send a message to : [[email protected]][email protected][/email] Leave the subject area BLANK In the message body, write unsubscribe TECHNET21E ______________________________________________________________________________ The World Health Organization and UNICEF support TechNet21. The TechNet21 e-Forum is a communication/information tool for generation of ideas on how to improve immunization services. It is moderated by Claude Letarte and is hosted in cooperation with the Centre de coopération internationale en santé et développement, Québec, Canada (www.ccisd.org ______________________________________________________________________________